TrialBritish journal of clinical pharmacology2011

Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.

Pierre-François Lesault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.